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1INTRODUCTION
                        Introduction
In  1954,  Lil lehei  f irst  reported  the  effective  use  of 
Extracorporeal  circulation  in  the  repair  of  CHD  using  cross 
circulation  with  the  patient's  parent  functioning  as  the  oxygenator. 
Gibbon  first  described  and  used  a  mechanical  extracorporeal 
oxygenator,  which  he  termed  the  Heart-Lung  machine.  On  May  6, 
1953,  Gibbon  performed  the  first  successful  Open  heart  surgery 
using  a  Heart-Lung  machine  while  repairing  an  Atrial  Septal  defect. 
Increasingly complex repairs subsequently became possible with the 
refinement  of  Cardiopulmonary  bypass  (CPB)  techniques  and  the 
use of  hypothermic circulatory arrest  that  Barratt-Boyes et  al  (1971) 
and Castaneda et al  (1974) popularized. Further refinements in CPB 
hardware  and  techniques,  perfusion  methods,  myocardial  and  Brain 
protection  over  the  past  2  decades  contributed  to  improved 
outcomes of surgical treatment of CHD.
The  use  of  CPB  is  associated  with  significant  cerebral 
morbidity.  The  two  main  clinical  manifestations  of  Brain  injury  after 
CPB  are  Stroke  and  Cognitive  decline.  Cognitive  decline  has 
increasingly  been  recognized  as  a  complication  after  cardiac 
surgery.  Although  important  advances  in  techniques  for 
perioperative anesthesia, surgery,  and the protection of  organs have 
resulted  in  substantial  reductions  in  age-adjusted  and  risk-adjusted 
mortality,  the  incidence  of  cognitive  decline  has  changed  litt le  over 
the  past  years.  The  quality  of  l ife  of  patients  undergoing  cardiac 
surgical procedures has recently received much attention, especially 
with  respect  to  the  effect  of  such  procedures  on  cognitive  and 
neuropsychologic  outcomes.  Elderly  patients  with  multiple  health 
problems,  who  are  at  higher  risk  than  other  groups  of  patients  for 
Neurologic  and  Neurocognitive  problems,  are  now  able  to  undergo 
surgical  procedures  relatively  late  in  l ife  without  serious  concern 
about  loss  of  l ife.  However,  they  are  at  substantially  increased  risk 
for  Central  Nervous  System dysfunction and,  in  particular,  Cognitive 
decline after  surgery.  The clinical  and financial  implications of  these 
problems  can  be  profound,  since  prolonged  hospitalization  and  an 





This  prospective  study  has  been  conducted  to  evaluate  various 
factors  associated  with  Cognitive  dysfunction  and  is  aimed  at 
improving the surgical outcome in our patients. The aim of this study 
is
             To perform pre operative Cognitive evaluation and to study 
the incidence of Cognitive decline after cardiac surgery.
1. To  assess  the  manifestations  of  Neurocognitive  decline 
after Cardio pulmonary bypass
2. Comparison  between  results  concerning  Cognitive  decline 
in  our  patients  and  previous  clinical  reports  and 
identif ication  of incremental risk factors.
3. To  discuss  various  modalit ies  in  improving  the  surgical 
outcome.
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MATERIALS AND METHODS
Materials and methods 
Subjects
 This  study was conducted at  The Department  of  Cardiothoracic 
Surgery,  Madras Medical College and Government General Hospital, 
Chennai  from November  2004  to  January  2007.  Institutional  ethical 
clearance  was  obtained  for  the  study.  95  patients  who  underwent 
elective  open-heart  surgery  in  different  units  were  taken  up  for  the 
study.  Patients  who  had  emergency  surgery,  who  underwent 
procedures  in  Deep  Hypothermia  or  Circulatory  arrest,  who  had  a 
History  of  Stroke,  Seizures  or  previous  Psychiatric  pathology, 
Carotid  artery  disease  or  Cardiac  tumors  were  not  included  in  the 
study.  Also patients who had less than eighth standard of  education 
or  who  could  not  read  were  excluded.  Evaluation  was  done  pre 
operatively;  7  days  post  operatively  and  during  the  6 t h  month  of 
follow up.
Procedures
  All  patients  were  subjected  to  a  standardized  anesthetic  and 
bypass  management.  Anesthesia  was  induced  with  Midazolam 
hydrochloride,  50 to 100 µg/kg,  and Fentanyl  citrate,  5 to 10 µg/kg - 1 /
min - 1.  Vercuronium  bromide  was  given  as  needed  to  maintain 
complete neuromuscular blockade.    The procedures were performed 
under  moderate  hypothermia  (32°C  -  34°C),  using  a  nonpulsatile 
pump  flow  of  2.4  L/m2 per  minute  at  maximal  pump  force,  a 
membrane  oxygenator  (Sorin  Monolyth  pro),  and  40-µm  Membrane 
fi lters.  Anticoagulation was adjusted at an Activated Clotting Time of 
longer  than  400  seconds.  Mean  arterial  pressure  was  maintained  at 
60 mm Hg or higher
Neuropsychological assessment
The following instruments assessed cognitive functioning:  
I. Montgomery  –  Asberg  Depression  rating  scale for 
assessment  of  Depression.  This  rating  is  based  on  a  clinical 
interview,  which  moves  from  broad  questions  about  symptoms 
to  more  detailed  ones  that  permit  rating  of  severity.  Score 
ranges  from  0  –  60  [0-6  normal  /  recovered,  7-19  mild 
depression,  20-34  moderate  depression,  35-60  severe 
depression].
II. Clinical  anxiety  scale to  assess  the  present  state  of  anxiety 
by  elicit ing  information  of  how  the  patient  felt.  This  has  been 
derived from Hamilton Anxiety scale and score ranges from 0 – 
24  [0-4  normal  /  recovered,  5-10  mild  anxiety,  11-16  moderate 
anxiety, 17-24 severe anxiety].
Mini  mental  state  examination  is  a  brief,  quantitative  measure  of 
Cognitive  status  in  adults.  The  test  has  a  range  of  30  points,  from 
normal  (30)  to  severe  impairment  (0).  Cut  off  score  of  23  has  been 
suggested for presence of Cognitive impairment.
III. Trail  making  test,  A  and  B  from  the  Halstead-Reitan 
Neuropsychological  test battery requires  subjects to connect, as 
quickly as possible,  a series of  numbers (part  A,  1-2-3 etc)  and 
letters  and  numbers  in  alternating  sequence  (part  B,  1-A-2-B 
etc).  The  tests  are  good  predictors  of  general  mental  abil ity, 
visual and nonverbal intell igence.  
IV. PASAT  (Paced  Auditory  Serial  Addition  Test),  to  add  the 
number  just  presented to  the one immediately  preceding it  and 
say  that  sum  aloud.  The  integrity  of  the  attentional  processes 
and rate of information processing are assessed in this test.
Definitions of Decline
 To  determine  the  presence  and  extent  of  cognitive  change,  we 
used the following criteria:  
I. Standard  deviation  (SD). Decline  of  more  than  1  SD  from 
baseline  test scores. 
II. 20%  change. Decline  in  test  scores  by  at  least  20%  from 
baseline  test scores.
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REVIEW OF LITERATURE
  The  impact  of  Cardiac  surgery on the  Bra in  is  multifactorial.  Early 
postmortem  studies  emphasized  the  role  of  anoxia  in  causing  injury  to 
arterial  border  zone  regions,  in  particular  the  hippocampi.1 - 3  More 
recently,  the  most  popular  explanation  for  Cognitive  changes  is 
Microemboli  delivered  to  the  bra in  dur ing  surgery.  These  can  be  either 
air or particulate (atheromatous  matter, fat, platelet aggregates,  etc). 
         E lectron micrograph of  blood during CPB showing fat  droplets.
The  measurement  of  the  occurrence  of  Microemboli  dur ing  cardiac 
surgery can  be  achieved  with  the  use  of  Transcranial  Doppler  where  the 
Microemboli  produce  a  characteristic  High  frequency  disturbance  "HITS" 
(High  intensity  transcranial  signals).  Transcranial  Doppler  is  now 
commonly  used  in  cardiac  surgery research  but  researchers  are  unable  to 
dist inguish between gaseous and particulate  Microemboli.  
                         Trans cranial  Doppler  showing “HITS”
Histopathologic  and  MRI  studies  have  demonstrated  the 
vulnerabil ity  of  specific  brain  regions  to  intraoperative  injury  in 
cardiac  surgery  employing  Cardiopulmonary  Bypass  (CPB).  The 
most common sites of MRI defined infarction are within  the deep sub 
 
cortical  white  matter,  basal  ganglia,  caudate  nucleus,  and  corona 
radiata.4 -10
Cut  sect ion of  brain showing pet icheal  haemorrhages after  CPB
 
Cut  sect ion of  brain showing pet icheal  haemorrhages after  CPB
Histology showing  embolus  inside  blood  vessel  wi th  surrounding  inf lammatory 
cel ls
Neuropathological  studies  have  identif ied  the  occurrence  of 
what  have  been  termed  small  capil lary  and  arteriolar  dilatations 
(SCADs)  in the brains of both patients who have died during cardiac 
surgery and  dogs  that  underwent  experimental  cardiopulmonary 
bypass,  but  not  in  those  who  have  not  been  on  extracorporeal 
circulation.9  It  has been assumed that there is a relation between the 
microemboli  and SCADS,  though the SCADS appear  to  resolve over 
time. 
Patient  characteristics  such  as  age  and  disease  (such  as  the 
extent  of  atheroma), anaesthetic  and  bypass  intervention 
equipments have an  impact  on  Neuropsychological  outcome,  much 
work  has  focused  on  the  impact  of  different  techniques  and 
equipment  on  Neuropsychological  performance.   The  most  direct 
attempt  to  deal  with  the  potential  deleterious  effects  of  Coronary 
artery bypass  graft ing  has  been to  examine  the  impact  of  modifying 
bypass  equipment. 
The  role  of  Arterial  l ine  fi lters  in reducing  the  impact  of 
Microemboli  during  cardiac surgery has  been  explored  in a  number 
of  studies.  Padayachee  and  colleagues20  and  Pugsley  and 
colleagues21  found  the  introduction  of  an  Arterial  l ine  fi lter 
significantly  reduced  the  number  of  emboli  detected  at  the  Middle 
cerebral  artery  during  CABG.  One study found  significantly  reduced 
deficits in  the fi lter group (8% v 27%) eight weeks after surgery.21  
Comparisons  between Bubble and Membrane oxygenators have 
shown  significant  differences  in the  occurrence  of  emboli  as 
assessed  using  Retinal  f luorescein angiography  and  some 
suggestion  of  reduced Neuropsychological  deficits  in the  Membrane 
oxygenator group.22
 A comparison between pulsatile and non-pulsatile f low failed to 
find  any  advantages  for  either  procedure.23  Whether  these  two 
modes of  perfusion are able to lead to perceptible differences  in the 
brain is  questionable,  as  Doppler  recordings  in the  Middle  cerebral 
artery  tend  to  show  non-pulsatil i ty  of  f low  even  when  pulsatile 
bypass is  used. 
The  use  of  Hypothermic  perfusion  during  Cardiopulmonary 
bypass has been based on the protective effects of  low temperature 
in l imit ing the effects of cerebral ischemia. A number of studies  have 
examined  whether  Hypothermic  bypass  reduces  the  impact  of 
cardiac surgery on  Neuropsychological  tests;  they  have  not 
presented  a  clear  picture.  Notably  one  large  study  found  a 
significantly  higher  incidence  of  neurological  problems  in 
Normothermia,  which  was not  paralleled  in a subset  of  patients  who 
underwent  Neuropsychological  testing.24  The  issue  of  temperature 
during  bypass  is  more  complex  than  is  immediately  apparent.  For 
example,  what  is  termed  Normothermic  bypass  can  involve  a  range 
of  different  procedures  such  as  deliberately  re-warming  to  maintain 
normothermia,  to  letting  the  temperature  drift  during  bypass. 
Hypothermia  occurs  at  the  time  most  cardiac  manipulations  are 
conducted and therefore at the time when emboli  are likely to occur. 
In addition,  Hyperthermia  may  occur  during  re-warming  and  it  is 
possible that this is the time of most damage  to the  brain. 
Two  studies  that  examined  the  impact  of  pH management  both 
reported  advantages  for  the  alpha  stat  technique.23  Patel  and 
colleagues25  reported  less  disruption  to  autoregulation  in the  alpha 
stat  group,  offering  some  potential  explanation  for  the  differences 
found  between alpha stat and pH stat  regimens. 
harmacological interventions 
The mechanisms of Ischemic Brain damage are complex leading to  a 
range  of  possibil it ies  for  pharmacological  intervention  in CABG. 
Neuroprotection has been used  in cases of  Circulatory arrest  where 
preservation  of  Cognitive  function  as  assessed  by 
Neuropsychological  tests  has  been  demonstrated.  In CABG, 
however,  l itt le  evidence  of  neuroprotection  has  been  found.  Similar 
f indings  have  been  reported  in a  study  of  Prostacyclin27 . Calcium 
channel  blockers  and  GM1 gangliosides  have  both  been  applied  in 
randomised controlled  studies but only on small numbers.18  28  
One  large  study17  used  an  NMDA  receptor  antagonist 
(remacemide  [(+)  2-amino-N-(methyl-1,2-diphenylethil)-acetamide] 
hydrochloride)  in a  large  prospective  double  blind  randomised  trial. 
Patients  receiving  Remacemide  had  significantly  greater 
preservation  of  learning  on  the  Neuropsychological  battery 
compared to  the  placebo group.  The  increased capacity for  learning 
in  the remacemide group may therefore be considered a reflection  of 




This  study  was  conducted  in  95  eligible  patients,  47  of  whom 
were  females  and  48  males.  The  mean  age  of  the  patients  was 
30.66 ±12.33 (females 28.35  ±10.18, males 33.5 ±13.95). 6 patients 
did not turn up for follow up at 6 months.
29  patients  underwent  surgical  correction  for  Atrial  septal 
defect, 
7 patients for Ventricular septal defect,
1 patient had Ventricular septal defect with Aortic regurgitation, 
1 patient had Left Atrial myxoma, 
30 patients underwent surgery for Mitral valve disease 
Mi t ra l  s tenos i s 5
M i t ra l  r egu rg i t a t i on 15
Mi t ra l  Res tenos i s 1
M i t ra l  s tenos i s  w i t h  LA  c lo t 3
M i t ra l  s tenos i s  w i t h  regu rg i t a t i on 6
9 patients had Aortic valve disease
B icusp id  Ao r t i c  Va l ve 1
Aor t i c  s tenos i s 1
Aor t i c  r egu rg i t a t i on 4
Aor t i c  s tenos i s  w i t h  regu rg i t a t i on 2
Rup tu re  o f  S inus  o f  Va l sa l va 1
4 patients had both Aortic and Mitral valve disease.
Aor t i c  r egu rg i t a t i on  w i t h  M i t ra l  r egu rg i t a t i on 3
Aor t i c  r egu rg i t a t i on  w i t h  M i t ra l  s tenos i s 1
14 patients had coronary artery disease and underwent  bypass 
grafting.  Saphenous veins formed majority of  conduits used with the 
mean number of grafts being 2.08 ± 0.49.
Various  risk  factors  were  analysed  for  their  impact  on  the 
outcome. Patients had the following risk factors
Sm ok ing 22
A lcoho l 14
H yper t ens ion 14
D iabe tes  m e l l i t us 9
M yoca r d ia l  i n fa r c t i on 8
But  the  impact  of  the  following  risk  factors  on  the  Postoperative 
Cognitive decline was not significant.
Pulmonary hypertension based on pre operative 




Postoperative tests scores were almost similar in all  the three 
groups.
The mean Left Ventricular end diastolic dimension was 4.06 ± 
1.08cms, mean Left Ventricular end systolic dimension 3.08 ± 
0.81cms and Ejection fraction 55.92 ± 9.71 %. 
Patients underwent following surgeries
At r i a l  sep ta l  de fec t
Pe r i ca rd ia l  pa t ch  c l osu re 28
D i rec t  c l osu re 1
Ven t r i cu la r  sep ta l  de f ec t
Pa tch  c l osu re 5
D i rec t  c l osu re 2
Ven t r i cu la r  sep ta l  de f ec t  w i t h 
Ao r t i c  r egu rg i t a t i on
Pa tch  c l osu re  w i t h  Ao r t i c  va l ve 
rep lacem en t
1
M i t ra l  va l ve  d i sease
Mi t ra l  va l ve  rep lacem en t 28
Open  m i t ra l  va l vo tom y 2
Aor t i c  va l ve  d i sease Aor t i c  va l ve  rep lacem en t 8
Aor t i c  va l ve  and  M i t ra l  va l ve 
d i sease
Doub le  va l ve  rep lacem en t 3
Open  m i t ra l  va l vo tom y  w i th  Ao r t i c 
va l ve  rep lacem en t
1
Corona r y  a r te r y  d i sease Corona r y  a r te r y  b ypass  g ra f t i ng 14
Lef t  a t r i a l  m yxom a Exc i s i on 1
Rup tu re  o f  S inus  o f  Va l sa l va Exc i s i on  and  pa tch  c l osu re 1
The surgeries were performed in Hypothermia with the 
temperature at Cross clamp application 33.30 ± 0.74 ºc, Cross clamp 
duration 68.96 ± 30.04 mins, extra corporal circulation time 116.52 ± 
40.81 mins and post operative hospitalization period 13 ± 2.24 days.
Various postoperative adverse events that were identif ied are 
tabulated.
B leed ing 7
S te rnum  rev i s i on 3
Pers i s ten t  AF 6
Lo w ca rd iac  ou tpu t 4
M yoca r d ia l  i n fa r c t i on 2
W ound  i n fec t i on 14
Secondar y  Su tu r i ng 20
ARDS 1
 In  the study conducted,  we have analysed the incidence of  various 
Psychiatric  manifestations  by  battery  of  tests  before  and  after  surgery. 
The  incidence  of  Depression  based  on  the  Montgomery-  Asberg 
Depression rating scale is
The incidence 
of Anxiety 
based on The 
Clinical Anxiety scale is
Pre  Opera t i ve
%
Pos t  Opera t i ve
%
Fo l l o w Up
%
Mi ld 4 9 .5 6
Modera te  - 1 5
Pre  Opera t i ve
%
Pos t  Opera t i ve
%
Fo l l o w Up
%
Mi ld 3 19 8
Modera te  - 17 3
Seve re - 18 -
Severe - 25 -
And  the  incidence  of  Neurocognitive  dysfunction  based  on 
Cognitive assessment by a battery of tests is 46.3% in postoperative 
period and 13.7% at 6 months.
 The scores of various tests conducted in the study
Test Pre op
( M e a n ±  S D )  
Post op
( M e a n ±  S D )
Fol low up
( M e a n ±  S D )
MADS 4.59  ±  1 .5 15 .57  ±  13 .76 5 .44  ±  4 .11
C l i n i ca l  Anx ie t y  sca le 3 .22  ±  1 .2 10 .62  ±  7 .26 3 .69  ±  2 .64
MMSE 25 .48  ±  2 .26 20 .20  ±  3 .92 24 .51  ±  2 .46
TMT-A 69 .95  ±  13 .67 100 .36  ± 
24 .15
78 .85  ±  21 .16
TMT-B 127 .67  ± 
30 .46
170 .46  ± 
46 .21
137 .49  ± 
41 .68
PASAT 23 .81  ±  2 .61 29 .11  ±  5 .79 24 .22  ±  3 .38
Graphs of mean test scores.
Montgomery- Asberg Depression rating scale













pre op post op  fol up











pre op post op fol up
Trail making test – A
Trail making test – B







pre op post op fol up
7DISCUSSION
Discussion
 The  incidence  of  Neurocognitive  Dysfunction  in  the  study  is 
46.3%  in  postoperative  period  and  13.7%  at  6  months.  This  was 
comparable  to  the  incidence  in  studies  conducted  by  different 
groups.  
  Pos topera t i ve Fo l low up  (6  months)
D ieder ik  van  D j i k  e t  a l 1 4 4 % –  47  % 3.4  %–  19 .  4  %
Mark  Newmann e t  a l 1 3 53 % 24 %
Ernes t  e t  a l 1 1 27 % 21 %
Present  s tudy 46.3  % 13.7  %
 Lewis  and  Ernest  had  demonstrated  an  increase  in  the 
detection of Postoperative Cognitive decline with increase in number 
of tests in a battery. The incidence increased from 13.3 % to 49.4 % 
as  the  test  batteries  increased  from  2  to  7  tasks.  In  the  present 
study we used a Battery of 3 tests to evaluate the decline 
The Demographic factors in the study group was compared with 
two other study groups
There  was  a  higher  mean  age  and  consequently  a  higher 
incidence  of  Diabetes  and  Hypertension  in  the  other  study  groups 
but  neither  study  related  these  risk  factors  to  cognitive  decline  in 
post op period. 
Age Male  sex% Hyper tens ion% Diabetes%
Mark  Newmann e t  a l 1 3 60.9  ±  10 .6 74 .7 51.2 14
Ernes t  e t  a l 1 1 63.7  ±  10 .7 81 79 27
Car rasca l  e t  a l 1 5 67 ±  9 .67 58.3 45.5 23.5
Present  s tudy
30.66  ± 
12 .33
47.4 14.7 9 .5
Age wise analysis revealed gradual increase in postoperative 
Cognitive dysfunction with age. 
Age group Postopera t i ve Fo l low up  (6  months)
10  –  20 29  % 5  %
20  –  30 45  % 10 .5  %
30  –  40 57  % 14  %
40  –  50 53  % 15  %
50  a nd  ab ove 50  % 17  %
This  could  also  be  partially  attributed  to  Atrial  septal  defects 
forming  the  bulk  of  cases  in  the  10  –  20  years  age  group  and 
consequently  associated  with  shorter  cross  clamp  and  Extra 
corporeal circulation time.
Analysing the outcome of patients within the study group we could 
infer the following. 
 Anxiety,  Depression  and  Neurocognitive  dysfunction  was  higher 
among  female  patients.  Valvular  surgeries  and  Coronary  artery 
bypass  grafting  had  greater  Cognitive  decline  than  other 
A S D M V R A V R C A B G
F e m a l e M a l e F e m a l e M a l e F e m a l e M a l e  
X  C  t e m p 3 3 . 7 6 ± 0 . 5 6 3 3 ± 0 . 6 7 3 3 ± 0 . 5 6 3 3 . 3 7 ± 0 . 7 4 3 3 ± 0 . 8 1  3 3 . 2 9 ± 0 . 9 5 3 3 . 5 4 ± 0 . 7 8
X  C  t i m e 3 8 . 6 4 ± 2 0 . 2 2 4 1 . 2 ± 1 6 . 9 9 8 9 . 3 5 ± 1 5 . 2 0 7 9 . 8 8 ± 2 2 . 7 4 9 2 . 5 ± 8 . 8 1 9 4 . 2 8 ± 2 6 . 1 6 8 3 . 9 2 ± 2 3 . 0 8
E C C  t i m e 7 0 . 9 4 ± 2 7 . 3 7 8 2 . 3 ± 2 9 . 0 6 1 4 5 . 1 5 ± 1 7 . 3 6 1 3 4 ± 2 8 . 5 1 4 6 . 2 5 ± 1 7 . 0 1 1 5 4 . 4 3 ± 3 2 . 5 7 1 3 7 . 3 1 ± 2 8 . 7 7
M A D  P r e 4 . 4 1 ± 1 . 3 2 4 . 3 ± 0 . 6 7 4 . 8 ± 0 . 6 9 4 . 5 ± 0 . 7 5 4 . 7 5 ± 0 . 5 4 . 7 1 ± 0 . 7 6 4 . 7 7 ± 3 . 2 1
M A D  P O 1 3 . 1 1 ± 1 2 . 4 6 8 . 1 ± 1 1 . 3 0 1 2 . 4 ± 1 0 . 1 5 6 . 6 3 ± 2 . 1 3 1 1 . 7 5 ± 1 . 5 1 6 . 7 1 ± 1 3 . 8 3 3 . 8 5 ± 8 . 4 5
M A D  F O 6 . 8 8 ± 5 . 3 3 4 . 0 ± 1 . 4 1 5 . 2 3 ± 3 . 0 8 4 . 1 3 ± 1 . 2 5 4 . 3 3 ± 0 . 5 8 6 ± 4 . 1 0 7 ± 5 . 9
C A S  P r e 3 . 1 1 ± 1 . 2 1 2 . 7 ± 1 . 1 6 3 . 7 ± 1 . 5 2 2 . 7 5 ± 0 . 8 9 3 . 5 ± 0 . 5 8 3 . 4 2 ± 0 . 7 9 2 . 6 9 ± 1 . 1 1
C A S  P O 9 . 3 6 ± 7 . 7 7 4 . 4 ± 4 . 1 4 8 . 9 ± 6 . 4 8 8 . 8 8 ± 9 . 9 6 9 . 7 5 ± 2 . 0 6 1 0 . 7 1 ± 8 . 4 4 1 8 . 0 7 ± 4 . 5 4
C A S  F O 4 . 3 5 ± 3 . 8 8 2 . 5 ± 0 . 7 3 ± 1 . 0 8 2 . 8 7 ± 1 . 1 3 3 . 3 3 ± 0 . 5 8 4 . 5 ± 4 . 3 2 4 . 4 2 ± 3 . 1 7
M M S  P r e 2 6 . 5 2 ± 1 . 9 1 2 7 ± 2 . 5 8 2 4 . 9 5 ± 1 . 8 2 2 5 . 5 ± 1 . 6 0 2 6 ± 1 . 8 2 2 4 . 7 ± 1 . 1 1 2 3 . 9 2 ± 2 . 6 6
M M S  P O 2 1 . 8 8 ± 3 . 3 7 2 3 . 7 ± 3 . 1 6 1 8 . 6 ± 3 . 3 3 2 0 . 3 8 ± 3 . 3 8 1 9 . 7 5 ± 2 . 7 5 1 8 . 7 1 ± 2 . 9 8 1 7 . 3 8 ± 3 . 5 2
M M S  F O 2 5 . 1 8 ± 2 . 6 2 6 . 5 6 ± 2 . 1 3 2 3 . 6 1 ± 2 . 3 0 2 5 ± 1 . 4 1 2 3 . 6 7 ± 1 . 5 3 2 2 . 1 7 ± 2 . 4 8 2 2 . 9 2 ± 2 . 4 7
T M A  P r e 6 7 . 2 3 ± 1 4 . 4 6 5 7 . 1 ± 1 6 . 3 1 7 4 . 4 5 ± 1 0 . 9 8 7 5 ± 1 0 . 7 7 1 ± 9 . 3 1 7 6 . 1 4 ± 1 2 . 3 6 7 9 . 1 5 ± 9 . 7 5
T M A  P O 9 4 . 1 7 ± 1 8 . 6 8 7 7 . 7 ± 3 0 . 1 1 1 1 1 . 0 5 ± 2 3 . 3 1 1 4 . 2 5 ± 2 5 . 8 9 9 . 7 5 ± 9 . 5 4 1 0 1 . 8 6 ± 1 7 . 6 2 1 1 2 . 9 2 ± 1 6 . 8 4
T M A  F O 7 3 . 5 3 ± 1 8 . 5 6 2 . 3 3 ± 2 4 . 5 4 8 7 . 3 9 ± 1 8 . 9 2 9 1 . 3 8 ± 2 9 . 4 5 7 8 ± 3 . 4 6 7 9 . 3 3 ± 9 . 4 9 2 ± 1 9 . 2 4
T M B  P r e 1 2 7 . 0 6 ± 4 6 . 7 6 1 0 0 . 4 ± 2 4 . 4 4 1 3 1 . 7 ± 2 4 . 6 7 1 4 7 . 2 5 ± 2 6 . 4 1 1 3 0 ± 2 3 . 7 8 1 2 6 ± 1 5 . 4 6 1 4 6 . 1 5 ± 1 6 . 5 9
T M B  P O 1 6 0 . 6 5 ± 4 7 . 5 3 1 2 3 . 8 ± 3 3 . 9 0 1 7 9 . 9 ± 4 0 . 1 5 2 0 6 . 3 8 ± 4 7 . 1 6 1 5 9 ± 2 6 . 6 5 1 6 2 . 4 3 ± 3 1 . 5 8 2 0 0 . 9 2 ± 2 9 . 5 8
T M B  F O 1 3 1 . 9 4 ± 4 7 . 8 8 1 0 0 . 1 1 ± 3 1 . 4 3 1 4 3 . 9 4 ± 3 5 . 8 4 1 7 1 . 8 8 ± 4 7 . 8 1 3 6 . 6 7 ± 1 7 . 0 1 1 4 1 . 1 7 ± 3 2 . 5 3 1 6 7 . 1 7 ± 3 1 . 9 4
P A S  P r e 2 3 . 8 8 ± 2 4 . 5 2 4 . 5 ± 2 . 6 8 2 3 . 3 ± 2 . 0 5 2 3 . 5 ± 2 2 3 . 5 ± 1 2 2 . 7 1 ± 1 . 8 2 5 . 4 6 ± 2 . 9 9
P A S  P O 3 2 . 7 ± 8 . 9 5 2 5 . 8 ± 5 . 0 1 2 9 . 3 ± 8 . 7 1 2 8 ± 2 . 7 8 2 6 . 2 5 ± 2 . 0 6 2 9 . 5 1 ± 4 . 9 3 3 1 . 5 4 ± 5 . 8 8
P A S  F O 2 4 . 8 8 ± 3 . 2 6 2 4 . 8 9 ± 2 . 9 3 2 4 . 9 4 ± 2 . 8 6 2 4 . 5 ± 2 . 2 0 2 6 ± 3 . 6 1 2 2 . 8 3 ± 1 . 4 1 2 4 . 3 3 ± 4 . 0 8
procedures.  This  could  possibly  be  due  to  effect  of  Microemboli. 
Postoperative  Cognitive  decline  could  also  possibly  be  due  to 
increase  in  Cross  clamp  time  and  Extracorporeal  circulation  time. 
Also  patients  who  had  Neurocognitive  dysfunction  at  immediate 
postoperative  period  had  higher  incidence  of  dysfunction  at  6 
months follow up. 
Yolanda Carrascal  et  al  at  the  Department  of  Cardiac  Surgery, 
University  Hospital  of  Valladolid,  Spain  studied  various  aspects  of 
cognitive  decline  and  presented  their  f indings  at  the  53rd 
International  Congress  of  the  European  Society  for  Cardiovascular 
Surgery15 . This was compared with the present study
Compar ison of  present  s tudy w ith  Carrascal  e t  a l  s tud y
Yolanda  Car rasca l  e t  a l Present  s tudy
Age 67 ±  9 .67 30.66  ±  12 .33
LVEF 62.42  ±  11 .72 55.92  ±  9 .71
Num.  g ra f ts 2 .57  ±  0 .96 2 .08  ±  0 .49
Cross-c lamp t ime (m in) 62 .27  ±  22 .80 68.96  ±  30 .04
Ext racorporea l  c i rcu la t ion  t ime (m in) 84 .87  ±  27 .6 116.52  ±  40 .81
Postopera t i ve  f o l low-up  (days) 7 .67  ±  5 .38 13 ±  2 .24
Preopera t i ve  MMS score* 29 .29  ±  3 .42 25.48  ±  2 .26
Pos topera t i ve  MMS score* 30 .62  ±  3 .91 24.51  ±  2 .46
PASAT preopera t i ve  score 27.04  ±  11 .05 23.81  ±  2 .61
PASAT pos topera t i ve  score 25.81  ±  11 .83 29.11  ±  5 .79
PASAT score  fo l low up 27.93  ±  13 .11 24.22  ±  3 .38
They had reported a higher incidence of decline with older age and 
Valvular heart surgery. In the present study, Female sex, Valvular 
surgeries and Coronary artery bypass grafting had greater Cognitive 
decline than other procedures. Coronary artery disease and Valvular 
heart disease formed majority of patients in our study group and 
were associated with higher incidence of decline.
Newmann  et  al  from  the  Neurological  outcome  research  group 
in  their  study  of  261  patients  reported  old  age,  higher  baseline 
Neurocognitive  function  and  lower  educational  levels  as  Predictors 
of  long term Cognitive decline13  26 .  Sex,  Duration  of cardiopulmonary 
bypass,  and  Duration  of  Aortic  cross  clamping  were  not  significant 
factors  though  Left  Ventricular  Ejection  fraction  had  some 
significance indicating that patients with Cardiac dysfunction may be 
at increased risk of Postoperative Cognitive Decline. 
Compar ison of  present  s tud y w i th  New mann et  a l  s tudy
Newmann e t  a l Present  s tudy
Age 60.9  ±  10 .6 30 .66  ±  12 .33
Male  sex  % 74.7 50.5
LVEF 51.7  ±  11 .9 55 .92  ±  9 .71
Cross-c lamp t ime (m in) 47 .8  ±  18 .3 68 .96  ±  30 .04
Ext racorporea l  c i rcu la t ion  t ime (m in) 111.6  ±  34 .5
116.52  ± 
40 .81
TMT -  B  p reopera t i ve  score 142.24  ±  73 .56
127.67  ± 
30 .46
TMT -  B  pos topera t i ve  score 158.77  ±  81 .81
170.46  ± 
46 .21
TMT -  B  score  fo l low up 106.77  ±  64 .27
137.49  ± 
41 .68
Though the results of both the study groups were comparable, we 
did have a significant decrease in Cognitive function with prolonged 
cross clamp duration and Extracorporeal circulation time. This could 
probably be due to higher numbers of valvular surgeries in our study 
group and consequently higher rates of Microembolic injury.
However results of different studies cannot be directly compared 
even when the statistical criteria for change are the same. Results 
need to be more cautiously examined relative to the size and 
composition of Neuropsychological assessment batteries.
8CONCLUSION
Conclusion
Neurocognitive  Dysfunction  is  a  frequently  occurring 
complication.  The  results  confirm  a  High  Incidence  of  Cognitive 
decline.  The  incidence  in  our  study  was  46.3%  in  the  immediate 
postoperative period and 13.7% at 6 months.
Female  patients  who  constituted  49% of  the  study group  had 
a  Higher  Incidence  of  Anxiety,  Depression  and  Neurocognitive 
dysfunction.
Patients  with  Lower  Ejection  Fraction  pre  operatively  had 
Higher  rates  of  Cognitive  decline.  This  could  be  due  to  lower 
baseline Neurocognitive function in this group of patients.
Valvular  heart  surgeries  and  Coronary  artery  bypass  grafting 
were also associated with Higher  cognitive decline.  These surgeries 
were  associated  with  Prolonged  Cross  clamp  time  and 
Extracorporeal  circulation  time.  Extracorporeal  circulation  causing 
microscopic  air  embolism  and  Cerebral  and  Systemic  Inflammatory 
Activation  may be  responsible  for  transient  disturbance  of  Neuronal 
Metabolism.  Microscopic  Air  embolism  could  result  in  Diffuse 
Cerebral Hypoxemia. However we performed no transcranial Doppler 
measurements to visualize and confirm the emboli.
Lower  baseline  Neurocognitive  function  was  also  associated 
with  Higher  rates  of  Cognitive  decline.  Pre  surgical  counseling  by 
Psychologists  may  probably  help  in  improving  the  Postoperative 
Psychological Status. 
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Nam e Age Sex M /  F
IP  no A g e  g r o u p 1 0  -  2 0 2 0  –  3 0 3 0  –  4 0 4 0  –  5 0 ≥  5 0
Educa t i on L i t e r a t e  (up to 8th std) H i g h  S c h o o l G r a d u a te P o s t  g r a d u a t e
Risk factors:
Sm ok ing + -
A lcoho l + -
H yper t ens ion + -
Diabe tes  m e l l i t us + -
Rena l  i nsu f f i c i enc y + -
COPD + -
Ca lc i f i ca t i on  o f  Va l ves + -
Prev ious  M I + -
PHT Ni l m i l d modera te seve re
D iagnos i s :
C o n g e n i t a l  h e a r t  d i s e a s e Clot Calcification Vegetation
M i t r a l  v a l v e  d i se a se stenosis regurgitation + / - + / - +/ -
A o r t i c  v a l v e  d i se a se stenosis regurgitation + / - + / - + / -
C o r o n a r y  a r t e r y  d i s e a s e Left main Single vessel Two vessel Three vessel
N YH A  C l a s s I II III IV
R h y t h m sinus AF Other
Pre  Op  Card iac  d im ens ions :
Le f t  Ven t r i c l e  Vo lum e  –  D ias to le
Le f t  Ven t r i c l e  Vo lum e  –  S ys to le
Le f t  Ven t r i c l e  E jec t i on  f r ac t i on
Surge r y :
Congen i t a l  hea r t  d i sease
Mi t ra l  va l ve  su rge r y Va l ve  rep lacem en t Va l ve  repa i r
Ao r t i c  va l ve  su rge r y Va l ve  rep lacem en t Va l ve  repa i r
CABG –  No  o f  g ra f t s L IMA /  SVG 1 2 3 4
Procedu re  de ta i l s :
Tem pera tu re  a t  C ross  c l am p ing
Cross  c l am p  du ra t i on
Ex t ra  co rpo ra l  c i r cu la t i on  du ra t i on
Pos t  ope ra t i ve  pe r i od
Adverse  even ts :
a .  B leed ing b .  S te rnum  rev i s i on c .  Pe rs i s ten t  AF
d .  Lo w ca rd iac  ou tpu t e .  M yoc a rd ia l  i n fa r c t i on f .  S t roke
g .  W ound  i n fec t i on h .  Sec .  Su tu r i ng i .  ARDS
j .  A r rh ythm ias k .  Sac ra l  so re
Neurops ycho log i c a l  m easu res :
Tes t P re  op Pos t  op Fo l l o w up
MADS
Cl in i ca l  Anx ie t y  sca le
MMSE
TMT-A
TMT-B
PASAT
